Physician profile
Steven W Bailey
NPI 1487754750
$1,460.83
in general payments reported to CMS, 2019-2025
11 companies · $32.95 in 2025
The $32.95 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $724 · 2020: $372 · 2021: $275 · 2022: $56.25 · 2025: $32.95.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $784.39 | 2019-2021 | |
| Pfizer INC. | $145.62 | 2019-2020 | |
| Horizon Therapeutics Plc | $127.28 | 2019 | |
| Comsort, INC | $100.00 | 2019 | |
| Merck Sharp & Dohme LLC | $67.88 | 2019 | |
| Melinta Therapeutics, LLC | $35.71 | 2019 | |
| Alfasigma USA, INC. | $33.57 | 2020 | |
| Paragon 28, INC. | $32.85 | 2020 | |
| Tactile Systems Technology INC | $26.90 | 2021 | |
| Arthrosurface Incorporated | $11.78 | 2019 | |
| Orthofix Medical, INC. | $5.65 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.